For instance, recent studies reported pathogenic variants in PARK2 and LRRK2 in Spanish PD patients, and rare variants in ATP13A2 and GIGYF2 that may contribute to PD risk on a population scale [88]. The gene discussed is ATP13A2; the disease is Parkinson disease.